Condition
Painful Diabetic Neuropathy (PDN)
Total Trials
4
Recruiting
2
Active
2
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
25%
1 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (3)
P 4 (1)
Trial Status
Recruiting2
Enrolling By Invitation1
Completed1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT07250828Not ApplicableEnrolling By InvitationPrimary
Efficacy and Feasibility of BurstDR SCS in Painful Diabetic Neuropathy
NCT07509671Not ApplicableRecruitingPrimary
The Treatment of Painful Diabetic Neuropathy With Diet
NCT07195045Not ApplicableRecruitingPrimary
Thai PainPREDICT Validation Study
NCT02842554Phase 4CompletedPrimary
Training "Pain Connoisseurs" for Efficient Analgesic Proof-of-Concept Studies
Showing all 4 trials